Cargando…
Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipid Remodeling
Esophageal cancer is a type of gastrointestinal carcinoma and is among the 10 most common causes of cancer death worldwide. However, the specific mechanism and the biomarkers in the proliferation and metastasis of esophageal tumors are still unclear. Therefore, the development of several natural pro...
Autores principales: | Li, Huiying, Zhang, Cheng, Zhang, Min, Yao, Qianqian, Yang, Huaigu, Fan, Linlin, Zheng, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358378/ https://www.ncbi.nlm.nih.gov/pubmed/32733803 http://dx.doi.org/10.3389/fonc.2020.01094 |
Ejemplares similares
-
Kiss1 Inhibits the Proliferation of Nasopharyngeal Carcinoma Cells Via Activation of the LKB1/AMPK Pathway
por: Li, Tingting, et al.
Publicado: (2022) -
AMPK potentiation by LKB1 isoforms
por: Thibert, Chantal, et al.
Publicado: (2015) -
LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022) -
ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators
por: Cai, Zhonglin, et al.
Publicado: (2022) -
Connecting LKB1 and AMPK links metabolism with cancer
por: Moore, Pete
Publicado: (2003)